PRQR
ProQR Therapeutics BV
1.70$
+0.0%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | -268.9% | – | |
| – | +281.0% | +159.4% | -14.5% | -6.9% | +106.9% | +14.8% | -1.1% | +8.2% | -0.3% | +9.9% | -2.1% | |
| – | +87.6% | +102.5% | +64.0% | -19.9% | +182.5% | -13.9% | -20.7% | -53.8% | +8.3% | -18.1% | +57.8% | |
| – | – | – | +238.3% | -18.0% | +44.0% | -74.1% | +262.7% | -105.8% | – | – | – | |
| – | -41.6% | +125.0% | -88.6% | +689.0% | +30.9% | -423.1% | – | -120.0% | – | -127.1% | – | |
| – | +7.4% | +91.8% | -95.2% | +157.9% | +85.9% | +59.3% | -47.6% | +46.3% | +93.6% | +3.4% | -28.1% | |
| – | +7.4% | +91.8% | -95.2% | +157.9% | +85.9% | +59.3% | -54.0% | +65.2% | – | -195.2% | -75.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | -85.7% | +1,284,350.0% | +231.1% | -42.7% | – | – | – | – | – | – | |
| – | +36.8% | -84.1% | +167.9% | +46.8% | +4.3% | +845.4% | +95.0% | -267.9% | -94.2% | -39.8% | +20.4% | |
| – | -98.6% | -78.0% | +7,362.2% | +232.8% | -43.4% | -71.1% | +843.7% | -122.6% | -92.6% | – | -102.6% | |
| – | -116.5% | – | – | – | -88.9% | -666.9% | – | -183.0% | – | +26.2% | -287.0% | |
| – | – | – | – | – | – | – | – | – | – | -287.4% | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.